HOME PAGE

SEARCH BY
SUBJECT


USING FOODS INSTEAD OF DRUGS FOR HEALTH

NEW ITEMS THIS MONTH

SEARCH BY SUBJECT

NEW THIS MONTH
Anti-Aging
Allergies
Arthritis
Asthma
Cancer
Colds
Comments
Cooking
Crohn's, Gastro, IBS
Drug-Herb Dangers
Diabetes
Epilepsy
Exercise
F.A.Qs
Foods
FOUNTAIN
OF YOUTH
Heart Problems
Herbs
Links
Losing Weight
Menopause
Men's Health
Nutrients
Osteoporosis
Our Book
Pregnancy
Recipes
Shoulder Pain
Soy
Thyroid
Vitamins
Women's Health
Testimonials
Past Issues
SEARCH BY
SUBJECT

 

 

ARTHRITIS

back to Arthritis index

Celebrex Drug Costs 100 Times Aspirin And Provides Less Benefits

"Celebrate, Celebrate," say commercials for Celebrex, a modified form of aspirin for arthritis. Please hold the celebration!  Vioxx, by the way, is a similiar drug.

The benefit to users of these aspirin-substitute drugs is that those who are subject to stomach distress from aspirin may be able to tolerate the substitutes. The benefit to the companies making the drugs is in the hundreds of millions of dollars. But there is a cost to their users beside money.

"Celebrex. The first arthritis medicine that targets only the COX-2* enzyme," say the present ads.

True. But at what deficit to the patient? For those not stomach-sensitive to plain old aspirin, there is possibly an increased risk of cancer. Aspirin, shown to reduce the risk of colon cancer reduces the inflammatory enzymes COX-1 and 2 in the blood.

Now research by the noted inflammation experts Dr. Desmond J. Fitzgerald and Joseph F. Murphy** have shown that at least experimentally, the factor that stimulates angiogenesis, which provides fresh blood supplies to tumor cells***uses COX-1 to do its dirty work. So, by inhibiting COX-1, which aspirin does but the new substitutes don't, one may actually help destroy tumor cells. This would be no small benefit for aspirin users but not for Celebrex and Vioxx takers.

*COX is an abbreviation for cyclooxygenase.

**Dept. of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin 2, Ireland. As reported in FASEB Journal, July, 2001.

***The signaling molecule that causes the building of new blood supplies to feed tumor cells is called VEGF—Vascular Endothelial Growth Factor. It is critical to this angiogenesis process.

back to Arthritis index

 

TOP OF PAGE

SEARCH BY SUBJECT - TABLE OF CONTENTS

THIS MONTH'S HEALTH BULLETIN NEWS


Smile If you find Health Bulletin interesting, please click here to "Tell a Friend"

 

Feedback
click here

  Home LIBRARY INDEX Allergies Arthritis Recipes Cancer Colds
  New items Cooking Diabetes Heart Herbs FAQs Live Longer
  Women Men Pregnancy Nutrients Osteoporosis Menopause Weight
  Vitamins Tell Friends   Soy Past issues Crohns Contact Us